Artemis Medicare Services Limited (NSE: ARTEMISMED), ISIN INE025R01021 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ARTEMISMED last traded at ₹299.10 (+7.90%), with a 52-week range of ₹202.85 to ₹305.55 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 58.39%, FIIs 12.29%, DIIs 2.40%, mutual funds 1.30%.
EquiSense Score (ECS): 84/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.